Research articlePublished 29 Aug 2025
Ovarian Cancer Immunotherapy: Overcoming Resistance, Predicting Response
AIIMS Bhopal, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Immune checkpoint inhibitors (ICIs) offer promise in ovarian cancer by reactivating anti-tumor immunity, but the immunosuppressive tumor microenvironment poses a challenge for durable efficacy. Combination strategies with chemotherapy, targeted therapies, and other immunotherapies are being investigated to overcome resistance. Biomarker identification is crucial for patient selection and response prediction. Addressing the immunosuppressive tumor microenvironment requires enhancing T-cell function, often through combinatorial approaches. Further research is needed to identify predictive biomarkers and optimize treatment strategies, including novel agents and personalized approaches, to improve outcomes in ovarian cancer
Keywords
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInsights in Gynecologic Oncology
- SubjectOncology & Cancer
- SubjectReproductive Medicine & Gynaecology
- BylineArticles whose byline prints “Dr. Rajiv Sharma”